Kelonia Therapeutics, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Not Applicable
Recruiting
- Conditions
- Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma ProgressionNeoplasms by Histologic TypeNeoplasmHemostatic DisordersVascular DisorderParaproteinemiasBlood Protein DisordersHematologic Disease and Disorders
- Interventions
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Kelonia Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT07075185
- Locations
- 🇦🇺
The Royal Prince Alfred, Camperdown, New South Wales, Australia
🇦🇺Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇦🇺The Alfred Paula Fox Melanoma and Cancer Centre, Melbourne, Victoria, Australia
News
No news found